BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/25/2026 9:41:26 AM | Browse: 1 | Download: 0
Publication Name World Journal of Stem Cells
Manuscript ID 116526
Country China
Category Medicine, Research & Experimental
Manuscript Type Basic Study
Article Title Therapeutic effects of human amniotic epithelial cell-derived and umbilical cord blood mesenchymal stem cell-derived exosomes on preeclamptic rats
Manuscript Source Unsolicited Manuscript
All Author List Lu-Yao Han, Wen-Zhu Zhang, Yu Zhang, Wan Zhong, Jing-Li Sun and Jian Shen
Funding Agency and Grant Number
Funding Agency Grant Number
Shenyang Science and Technology Plan in 2022 22-321-32-16
Corresponding Author Jian Shen, Department of Obstetrics and Gynecology, General Hospital of Northern Theater Command (Heping Campus), No. 5 Guangrong Street, Heping District, Shenyang 110000, Liaoning Province, China. shenjian99@sina.com
Key Words Human amniotic epithelial cells; Human umbilical cord blood mesenchymal stem cells; Preeclampsia; Exosomes; Vascular endothelial growth factor; Placental growth factor
Core Tip Preeclampsia (PE) is a serious obstetric syndrome, and effective therapeutic options are required urgently. This study demonstrates that exosomes derived from human amniotic epithelial cells and umbilical cord mesenchymal stem cells can function as innovative cell-free agents. Treatment with these exosomes effectively ameliorated key pathological features, including hypertension, proteinuria, and placental damage, in a rat model of PE. The underlying mechanisms involve multi-target modulation of angiogenic and inflammatory pathways. These findings highlight the clinical translation potential of exosomes derived from human amniotic epithelial cells and umbilical cord mesenchymal stem cells as novel therapeutic strategies for PE.
Citation Han LY, Zhang WZ, Zhang Y, Zhong W, Sun JL, Shen J. Therapeutic effects of human amniotic epithelial cell-derived and umbilical cord blood mesenchymal stem cell-derived exosomes on preeclamptic rats. World J Stem Cells 2026; In press
Received
2025-11-28 09:55
Peer-Review Started
2025-11-28 09:55
First Decision by Editorial Office Director
2025-12-18 09:10
Return for Revision
2025-12-18 09:10
Revised
2025-12-31 13:41
Publication Fee Transferred
2026-01-09 03:43
Second Decision by Editor
2026-03-25 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-03-25 09:41
Articles in Press
2026-03-25 09:41
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com